2026
article
OpenAlex
Oscar Hinojosa, Supreet Kaur, Leyla Bojanini, Joel Michalek et autres
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Oscar Hinojosa, Supreet Kaur, Leyla Bojanini, Joel Michalek et autres
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Annemarie Thompson, Claire Schenken, Julia Armstrong, Nicole M. Spencer et autres
Background: Peritoneal lymphomatosis is a rare manifestation of non-Hodgkin’s lymphoma in which the lymphoma seeds the peritoneum. Peritoneal lymphomatosis can be seen with aggressive/high-grade B-cell lymphomas such as diffuse large B-cell lymphoma, or, more rarely, Burkitt lymphoma. More commonly, ovarian or gastrointestinal …
us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Ysaith Orellana Ascencio, Supreet Kaur, Leyla Bojanini, Laura Reyes-Uribe et autres
Abstract Background: Primary central nervous system lymphoma (PCNSL) is a rare and highly aggressive non-Hodgkin lymphoma confined to the brain, spinal cord, leptomeninges, or eyes. Although potentially curable with high-dose methotrexate–based chemotherapy, real-world outcomes remain poor, with 5-year survival often under 35% …
us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Nikki Verma, Supreet Kaur, Aymen Baig, William Ciurylo et autres
Abstract Background Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma (HL), accounting for only 5% of HL cases (Hematol Oncol PMID: 40517549). It typically presents with an indolent course and excellent overall survival, although approximately 10% of …
us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Gabriel Giraldo Ospino, Leyla Bojanini, Erin Kaser, Victor Mendiola et autres
Abstract Background Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is an exceptionally rare malignancy, representing less than 1% of all mature T-cell lymphomas. In the United States, it occurs most commonly in Caucasian and African American patients (J Clin Oncol 41, 2023 [suppl 16; …
co, us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Erin Kaser, Leyla Bojanini, Vanessa Velázquez, Victor Mendiola et autres
Abstract Background: Cutaneous T-cell lymphomas are a group of lymphoproliferative disorders that are characterized by dermal infiltration by mature, malignant T cells (Blood PMID: 30635287). Mycosis Fungoides (MF) is the most common form with presenting features of skin plaques, patches or tumors, …
us, co
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Oscar Hinojosa, Supreet Kaur, Leyla Bojanini, Joel Michalek et autres
Abstract I) Background Enteropathy-associated T-cell lymphoma (EATL) represents 3% of peripheral T-cell lymphomas. It constitutes two thirds of all primary intestinal T-cell lymphomas in Europe and the USA, with a strong association with celiac disease (ISBN: 9789283245209). It affects patients in the …
us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Victor Mendiola, Leyla Bojanini, Erin Kaser, Daniel Rosas et autres
Abstract Background: Primary cutaneous (PC) anaplastic large cell lymphoma (-ALCL) represents 8% of cutaneous lymphoma cases. Unlike systemic ALCL, PC-ALCL follows an indolent course and has an excellent prognosis. The United States Surveillance, Epidemiology, and End Results (SEER) database reported 5- and …
us, se, co
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Carolina Vélez-Mejía, Laura Reyes-Uribe, Eleftheria Atalla, Ysaith Orellana Ascencio et autres
Abstract Background Approximately 5 per 100,000 people per year will develop Diffuse Large B-Cell Lymphoma (DLBCL) making it the most frequent subtype of non-Hodgkin lymphoma worldwide (DLBCL-Cancer STAT Facts; Blood PMID9166827). Given its high incidence, hematologists are generally familiar with the diagnosis …
us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Carolina Vélez-Mejía, Ysaith Orellana Ascencio, Laura Reyes-Uribe, Eleftheria Atalla et autres
Abstract Background: Burkitt lymphoma (BL) is a highly aggressive B-cell neoplasm that can be treated with curative intent using combination chemotherapy (Blood PMID33171490). While several frontline regimens are endorsed by national guidelines (NCCN v2.2025), data comparing outcomes by treatment facility type remain …
us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Daniel Rosas, Leyla Bojanini, Supreet Kaur, Erin Kaser et autres
Abstract Background Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma in the United States and Europe. While most patients experience an indolent disease course, a subset of patients present with aggressive disease, early relapses, and overall poor outcomes. Given its …
us
(code pays fourni par la source)